Viro - viro - Ravimiamet

orion corporation - pramipeksool - tablett - 0,18mg 100tk; 0,18mg 30tk

Viro - viro - Ravimiamet

sandoz pharmaceuticals d.d. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 10ml 1tk

Viro - viro - Ravimiamet

sandoz pharmaceuticals d.d. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 10ml 1tk

Viro - viro - Ravimiamet

teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 1tk

Viro - viro - Ravimiamet

teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 10ml 1tk

Viro - viro - Ravimiamet

teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 1tk

Viro - viro - Ravimiamet

sandoz pharmaceuticals d.d. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 1tk

Viro - viro - Ravimiamet

xellia pharmaceuticals aps - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 1tk

Euroopan unioni - viro - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - muud närvisüsteemi ravimid - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Euroopan unioni - viro - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunoloogilised ained - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.